Hypertension, Pulmonary

• 

  Subject Areas on Research

  • 3'UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension. 
  • A Multifaceted Approach to Pulmonary Hypertension in Adults With Congenital Heart Disease. 
  • A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension. 
  • A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. 
  • A non-invasive assessment of cardiopulmonary hemodynamics with MRI in pulmonary hypertension. 
  • A novel inhaled organic nitrate that affects pulmonary vascular tone in a piglet model of hypoxia-induced pulmonary hypertension. 
  • A reassessment of the echocardiogram in mitral stenosis. 
  • ACR Appropriateness Criteria® Suspected Pulmonary Hypertension. 
  • ACR Appropriateness Criteria® Suspected Pulmonary Hypertension: 2022 Update. 
  • ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine. 
  • Abnormal Pulmonary Venous Filling: An Adjunct Feature in the Computed Tomography Pulmonary Angiogram Assessment of Chronic Thromboembolic Pulmonary Hypertension. 
  • Abnormal left ventricular diastolic filling in chronic thromboembolic pulmonary hypertension: true diastolic dysfunction or left ventricular underfilling? 
  • Accuracy of high-resolution CT in identifying chronic pulmonary thromboembolic disease. 
  • Adding to the Denominator: A Case Report of Neuraxial Anesthesia for Cesarean Delivery in the Setting of Hemolysis, Elevated Liver Enzyme, Low Platelet, Thrombocytopenia, and Pulmonary Hypertension. 
  • Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers. 
  • An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation. 
  • An analysis of the pulsatile hemodynamic responses of the pulmonary circulation to acute and chronic pulmonary venous hypertension in the awake dog. 
  • An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. 
  • An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. 
  • An unusual case of pulmonary artery catheter malfunction. 
  • Anomalous right coronary artery origin from the pulmonary artery (ARCAPA) coexisting with obstructive atherosclerotic disease of the left coronary artery. 
  • Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons. 
  • Assessing right atrial function in pulmonary hypertension: window to the soul of the right heart? 
  • Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. 
  • Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. 
  • Association between Preoperative Dynamic Measures of Vascular Load and Postoperative Hemodynamics in Patients with Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Thromboendarterectomy. 
  • Association between oral sildenafil dosing, predicted exposure, and systemic hypotension in hospitalised infants. 
  • Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve Repair. 
  • Association of anemia and long-term survival in patients with pulmonary hypertension. 
  • Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. 
  • Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. 
  • Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: More Work to Be Done. 
  • Baseline body mass index does not significantly affect outcomes after pulmonary thromboendarterectomy. 
  • Biomarkers in Pulmonary Vascular Disease: Gauging Response to Therapy. 
  • Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrest. 
  • Brain death alters cardiopulmonary hemodynamics and impairs right ventricular power reserve against an elevation of pulmonary vascular resistance. 
  • Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension. 
  • CCR2 deficiency, dysregulation of Notch signaling, and spontaneous pulmonary arterial hypertension. 
  • Carbon monoxide promotes hypoxic pulmonary vascular remodeling. 
  • Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension. 
  • Case 1-2011: The challenges posed by a complicated pulmonary thromboendarterectomy. 
  • Cerivastatin Nanoliposome as a Potential Disease Modifying Approach for the Treatment of Pulmonary Arterial Hypertension. 
  • Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov. 
  • Chest pain in the nontraumatized patient. 
  • Chronic Thromboembolic Pulmonary Hypertension Perioperative Monitoring Using Phase-Resolved Functional Lung (PREFUL)-MRI. 
  • Chronic Thromboembolic Pulmonary Hypertension. The Journey from a Curiosity to a Cure. 
  • Chronic Thromboembolic Pulmonary Hypertension: An Update. 
  • Chronic Thromboembolic Pulmonary Hypertension: the Bedside. 
  • Chronic Thromboembolic Pulmonary Hypertension: the Bench. 
  • Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease. 
  • Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. 
  • Chronic major-vessel thromboembolic pulmonary hypertension. 
  • Chronic pulmonary thromboembolism: detection of regional hypoperfusion with CT. 
  • Chronic thromboembolic pulmonary hypertension in pediatric patients. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension. 
  • Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. 
  • Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes. 
  • Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. 
  • Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. 
  • Clinical Utility and Prognostic Value of Right Atrial Function in Pulmonary Hypertension. 
  • Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary Hypertension. 
  • Clinical correlates of angiographically diagnosed idiopathic pulmonary hypertension. 
  • Clinical implications of pulmonary hypertension in mitral stenosis. 
  • Commentary: Repair or replace-Potts shunt versus lung transplantation for refractory pediatric pulmonary hypertension. 
  • Commentary: Respect idiopathic pulmonary hypertension…or urine trouble. 
  • Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. 
  • Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta-analysis. 
  • Comprehensive assessment of right ventricular function in patients with pulmonary hypertension with global longitudinal peak systolic strain derived from multiple right ventricular views. 
  • Congenital heart disease and pulmonary hypertension. 
  • Congenital pulmonary capillary hemangiomatosis: Report of two cases and review of the literature. 
  • Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. 
  • Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. 
  • Contribution of Cardiac Implantable Electronic Devices to Thrombus Formation in Patients With Chronic Thromboembolic Pulmonary Hypertension. 
  • Coronary artery-to-pulmonary artery collaterals in chronic thromboembolic pulmonary hypertension. 
  • Correlation of left ventricular diastolic filling characteristics with right ventricular overload and pulmonary artery pressure in chronic thromboembolic pulmonary hypertension. 
  • Criteria for pulmonary thromboendarterectomy. 
  • Critical arrhythmia associated with pulmonary artery catheterization in a parturient with severe pulmonary hypertension. 
  • Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. 
  • Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy. 
  • De novo purine synthesis: a new target in pulmonary arterial hypertension? 
  • Deep hypothermic circulatory arrest and the femoral-to-radial arterial pressure gradient. 
  • Developing therapies for heart failure with preserved ejection fraction: current state and future directions. 
  • Diagnostic Evaluation of Chronic Thromboembolic Pulmonary Hypertension. 
  • Differences in Eccentricity Index and Systolic-Diastolic Ratio in Extremely Low-Birth-Weight Infants with Bronchopulmonary Dysplasia at Risk of Pulmonary Hypertension. 
  • Dilation of the coronary sinus on echocardiogram: prevalence and significance in patients with chronic pulmonary hypertension. 
  • Diminished aortic excursion in chronic thromboembolic pulmonary hypertension. 
  • Distinctive clinical features of portopulmonary hypertension. 
  • Dynamic mitral regurgitation without regional wall motion abnormality. 
  • Dyspnea and Pulmonary Hypertension with Diffuse Centrilobular Nodules. 
  • Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension. 
  • Echocardiographic estimation of pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension: utility of right heart Doppler measurements. 
  • Effect of Patent Foramen Ovale in Patients With Pulmonary Hypertension. 
  • Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension. 
  • Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. 
  • Effects of cardiopulmonary bypass and circulatory arrest on endothelium-dependent vasodilation in the lung. 
  • Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. 
  • Eisenmenger Syndrome in Pregnancy: When Is It Time for ECMO?: A Case Report. 
  • Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. 
  • Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension. 
  • Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. 
  • Epidemiology and risk factors for chronic thromboembolic pulmonary hypertension. 
  • Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association. 
  • Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT. 
  • Evaluation of patients for pulmonary endarterectomy. 
  • Evaluation of patients with suspected chronic thromboembolic pulmonary hypertension. 
  • Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappaB. 
  • Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. 
  • Extracorporeal Membrane Oxygenation for Hemodynamic Support. 
  • FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. 
  • Familial association of primary pulmonary hypertension and a new low-oxygen affinity beta-chain hemoglobinopathy, Hb Washtenaw. 
  • Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease. 
  • Features Associated With Discordance Between Pulmonary Arterial Wedge Pressure and Left Ventricular End Diastolic Pressure in Clinical Practice: Implications for Pulmonary Hypertension Classification. 
  • Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. 
  • Frequency of anomalies and hospital outcomes in infants with gastroschisis and omphalocele. 
  • GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension. 
  • Health insurance and racial disparities in pulmonary hypertension outcomes. 
  • Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database. 
  • Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension. 
  • Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. 
  • Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension. 
  • Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. 
  • Historical perspective: surgery for chronic thromboembolic disease. 
  • Hyperpolarized 129 Xe gas transfer MRI: the transition from 1.5T to 3T. 
  • Hypoplastic right lung with systemic blood supply and anomalous pulmonary venous drainage: reversal of pulmonary hypertension with surgical management in infancy. 
  • Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. 
  • Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. 
  • Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. 
  • Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis. 
  • Impact of Pulmonary Hypertension on Survival Following Device Closure of Atrial Septal Defects. 
  • Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile. 
  • Improving on the diagnostic characteristics of echocardiography for pulmonary hypertension. 
  • In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia. 
  • Infantile pulmonary hypertension associated with foreign body vasculitis. 
  • Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients. 
  • Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes. 
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension in infants. 
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. 
  • Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. 
  • Inhaled nitric oxide therapy increases blood nitrite, nitrate, and s-nitrosohemoglobin concentrations in infants with pulmonary hypertension. 
  • Inhaled nitric oxide, right ventricular efficiency, and pulmonary vascular mechanics: selective vasodilation of small pulmonary vessels during hypoxic pulmonary vasoconstriction. 
  • Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study. 
  • Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension. 
  • Insulin Growth Factor Phenotypes in Heart Failure With Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study. 
  • Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD. 
  • Interventional Management of Chronic Thromboembolic Pulmonary Hypertension. 
  • Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure. 
  • Intrapulmonary Activated Factor VII for Hemoptysis Complicating Pulmonary Thromboendarterectomy. 
  • Intrapulmonary Milrinone for Cardiac Surgery Provides Insight Into Precision Delivery of Aerosolized Vasodilators. 
  • Intravascular bronchioloalveolar tumor of the lung presenting as pulmonary thromboembolic disease and pulmonary hypertension. 
  • Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension? 
  • Isolated partial anomalous pulmonary venous return with intact atrial septum: a rare but treatable cause of pulmonary hypertension in adults. 
  • Kussmaul's Sign in Pulmonary Hypertension Corresponds With Severe Pulmonary Vascular Pathology Rather Than Right Ventricular Diastolic Dysfunction. 
  • Late "adult form" scimitar syndrome presenting with "infant form" complications. 
  • Left ventricular strain and strain rate by 2D speckle tracking in chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. 
  • Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function. 
  • Long-term outcome after pulmonary thromboendarterectomy. 
  • Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease. 
  • Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension. 
  • Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling. 
  • Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. 
  • Magnetic resonance imaging-derived parameter of portal flow predicts volume-mediated pulmonary hypertension in liver transplantation candidates. 
  • Management of Pulmonary Arterial Hypertension in the Pediatric Patient. 
  • Management of systemic and pulmonary hypertension. 
  • Massive pulmonary hemorrhage after pulmonary thromboendarterectomy. 
  • May-Thurner Anatomy in Patients With Chronic Thromboembolic Pulmonary Hypertension: An Important Clinical Association. 
  • Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease. 
  • Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. 
  • Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. 
  • Methodology and grading for pulmonary hypertension evidence review and guideline development. 
  • Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues. 
  • Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. 
  • Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension. 
  • Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension. 
  • Molecular biology of chronic thromboembolic pulmonary hypertension. 
  • Multiple Clustered Dermatofibromas Associated With Pulmonary Arterial Hypertension. 
  • Nebulized prostacyclin for pulmonary hypertension: a step in the right direction. 
  • Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertension. 
  • Nitric oxide improves transpulmonary vascular mechanics but does not change intrinsic right ventricular contractility in an acute respiratory distress syndrome model with permissive hypercapnia. 
  • Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension. 
  • Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload. 
  • Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart. 
  • One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension? 
  • Outcome after pulmonary thromboendarterectomy. 
  • Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance. 
  • PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. 
  • POEMS syndrome: a clue to understanding primary pulmonary hypertension? A review of current insights into the pathogenesis of primary pulmonary hypertension. 
  • Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. 
  • Partial anomalous pulmonary venous connection and pulmonary arterial hypertension. 
  • Percutaneous edge-to-edge leaflet repair: a solution to the risk-treatment paradox of mitral regurgitation complicated by pulmonary hypertension? 
  • Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies. 
  • Persistent tricuspid regurgitation and its predictor in adults after percutaneous and isolated surgical closure of secundum atrial septal defect. 
  • Pharmacologic management of perioperative pulmonary hypertension. 
  • Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. 
  • Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. 
  • Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis. 
  • Placenta growth factor in sickle cell disease: association with hemolysis and inflammation. 
  • Population pharmacokinetics of sildenafil in extremely premature infants. 
  • Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. 
  • Portopulmonary hypertension and the liver transplant candidate. 
  • Postoperative management of the patient undergoing pulmonary thromboendarterectomy. 
  • Predictors of patient response to pulmonary thromboendarterectomy. 
  • Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. 
  • Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. 
  • Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. 
  • Prospective evaluation of pulmonary artery pressures during pulmonary angiography performed with low-osmolar nonionic contrast media. 
  • Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. 
  • Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung. 
  • Protection of perfused lung from oxidant injury by inhibitors of anion exchange. 
  • Pulmonary Delivery of Therapeutic and Diagnostic Gases. 
  • Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study. 
  • Pulmonary Hypertension Subtypes and Mortality in CKD. 
  • Pulmonary Hypertension in Adults with Congenital Heart Disease. 
  • Pulmonary Hypertension in Pregnancy: A Report of 49 Cases at Four Tertiary North American Sites. 
  • Pulmonary Hypertension in the Era of Mechanical Circulatory Support. 
  • Pulmonary Hypertension. 
  • Pulmonary Vein Sign on Computed Tomography Pulmonary Angiography in Proximal and Distal Chronic Thromboembolic Pulmonary Hypertension With Hemodynamic Correlation. 
  • Pulmonary arterial hypertension and myeloproliferative disorders. 
  • Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. 
  • Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. 
  • Pulmonary cholesterol granulomas in patients with pulmonary artery hypertension: chest radiographic and CT findings. 
  • Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. 
  • Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. 
  • Pulmonary hemodynamics and blood flow characteristics in chronic pulmonary hypertension. 
  • Pulmonary hypertension and cor pulmonale. 
  • Pulmonary hypertension and elevated transpulmonary gradient in patients with mitral stenosis. 
  • Pulmonary hypertension and long-term mortality in aortic and mitral regurgitation. 
  • Pulmonary hypertension and nitric oxide depletion in sickle cell disease. 
  • Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. 
  • Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. 
  • Pulmonary hypertension and sleep apnea. 
  • Pulmonary hypertension associated with portal hypertension in a child with Williams syndrome--a case report. 
  • Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. 
  • Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes. 
  • Pulmonary hypertension in glycogen storage disease type I. 
  • Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis. 
  • Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. 
  • Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. 
  • Pulmonary vascular impedance analysis of adaptation to chronically elevated blood flow in the awake dog. 
  • Pulmonary vascular impedance and recipient chronic pulmonary hypertension following cardiac transplantation. 
  • Pulmonary vascular steal in chronic thromboembolic pulmonary hypertension. 
  • Pulmonary vascularity: radiographic considerations. 
  • Pulsed Doppler echocardiographic findings in total anomalous pulmonary venous drainage to the coronary sinus. 
  • Quantitative 129Xe MRI detects early impairment of gas-exchange in a rat model of pulmonary hypertension. 
  • Radiographic analysis of pulmonary vascular distribution: a review. 
  • Radiographic findings in pulmonary hypertension from unresolved embolism. 
  • Redistribution of pulmonary blood flow secondary to pulmonary arterial hypertension. 
  • Relation between pulmonary artery pressure and mitral stenosis severity in patients undergoing balloon mitral commissurotomy. 
  • Reoperative pulmonary thromboendarterectomy. 
  • Reply: Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoption. 
  • Resolution of vascular steal after pulmonary thromboendarterectomy. 
  • Response to inhaled nitric oxide predicts survival in patients with pulmonary hypertension. 
  • Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up. 
  • Reversal of right-ventricular dysfunction in pulmonary arterial hypertension following sildenafil therapy. 
  • Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy? 
  • Right Ventricular Function in Left Heart Disease. 
  • Right Ventricular Longitudinal Strain Reproducibility Using Vendor-Dependent and Vendor-Independent Software. 
  • Right ventricular adaptation to increased afterload after orthotopic cardiac transplantation in the setting of recipient chronic pulmonary hypertension. 
  • Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart. 
  • Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. 
  • Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension. 
  • Right ventricular pathology in chronic pulmonary hypertension. 
  • Right ventricular strain before and after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. 
  • Right-sided heart catheterization: de rigueur in sarcoidosis? 
  • Riociguat for pulmonary hypertension. 
  • Riociguat for pulmonary hypertension. 
  • Risk factors for immersion pulmonary edema: hyperoxia does not attenuate pulmonary hypertension associated with cold water-immersed prone exercise at 4.7 ATA. 
  • Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. 
  • S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. 
  • Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension. 
  • Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. 
  • Secondary Pulmonary Hypertension; getting down to the nuts and BOLT. Author's reply to Ranganath et al. 
  • Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension. 
  • Severe erythroderma as a complication of continuous epoprostenol therapy. 
  • Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome. 
  • Sildenafil Exposure in the Neonatal Intensive Care Unit. 
  • Sildenafil and retinopathy of prematurity risk in very low birth weight infants. 
  • Sildenafil improves walk distance in idiopathic pulmonary fibrosis. 
  • Single lung transplantation in patients with severe secondary pulmonary hypertension. 
  • Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension. 
  • Staging classification of aortic stenosis based on the extent of cardiac damage. 
  • Successful pulmonary thromboendarterectomy in a patient with Klippel-Trenaunay syndrome. 
  • Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. 
  • Surgical Management of Chronic Thromboembolic Pulmonary Hypertension. 
  • Surgical and Percutaneous Interventions for Chronic Thromboembolic Pulmonary Hypertension. 
  • Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. 
  • TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension. 
  • Textbook outcome in lung transplantation: Planned venoarterial extracorporeal membrane oxygenation versus off-pump support for patients without pulmonary hypertension. 
  • The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension. 
  • The Pathobiology of Pulmonary Arterial Hypertension. 
  • The coexistence of portopulmonary hypertension and hepatopulmonary syndrome. 
  • The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. 
  • The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. 
  • The impact of pulmonary hypertension on morbidity and mortality following major lung resection. 
  • The management of pulmonary hypertension secondary to chronic thromboembolic disease. 
  • The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use. 
  • The right atrium, more than a storehouse. 
  • The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. 
  • The use of supplemental hydrocortisone in the management of persistent pulmonary hypertension of the newborn. 
  • Therapeutic options for chronic kidney disease-associated pulmonary hypertension. 
  • Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study. 
  • Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia. 
  • Transpulmonary flux of S-nitrosothiols and pulmonary vasodilation during nitric oxide inhalation: role of transport. 
  • Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty. 
  • Treatment-related biomarkers in pulmonary hypertension patients on oral therapies. 
  • Treatment-related biomarkers in pulmonary hypertension. 
  • Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. 
  • Tricuspid annular plane systolic excursion in chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. 
  • Tumor necrosis factor-alpha-induced lung injury and its modulation by synthetic polynucleotide: a physiologic-morphometric analysis. 
  • Two Cases of Late Shone Syndrome With Pulmonary Hypertension: Heart-Lung Transplant or Valve Surgery? 
  • Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. 
  • Two-dimensional echocardiography. 
  • United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics. 
  • Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertension. 
  • Urban-Rural Disparities in Pulmonary Hypertension Mortality. 
  • Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension. 
  • Use of outcome measures in pulmonary hypertension clinical trials. 
  • Use of stellate ganglion blocks for chronic chest pain associated with primary pulmonary hypertension. 
  • Usefulness of Low Cardiac Index to Predict Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension. 
  • Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. 
  • Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. 
  • Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1. 
  • Vascular remodeling--the emerging paradigm of programmed cell death (apoptosis): the Francis B. Parker lectureship. 
  • Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. 
  • Volume-mediated pulmonary responses in liver transplant candidates. 
  • Worsening pulmonary hypertension after resection of arteriovenous fistula. 
• 

  Keywords of People

  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Gunn, Michael Dee, Professor of Medicine, Integrative Immunobiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology